Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity

Journal of the Royal Society Interface

Volumn 10, Issue 86, 2013, Pages

  Reich, Nicholas G ^a,b   Shrestha, Sourya ^c   King, Aaron A ^c,d   Rohani, Pejman ^c,d   Lessler, Justin ^b   Kalayanarooj, Siripen ^e   Yoon, In Kyu ^f   Gibbons, Robert V ^f   Burke, Donald S ^g   Cummings, Derek A T ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

^f ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^g GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cross protection; Dengue; Infectious disease modelling; Time series models

Indexed keywords

VIRUSES;

BANGKOK , THAILAND; CROSS-PROTECTION; DENGUE; IMMUNOLOGICAL INTERACTION; INFECTIOUS DISEASE MODELLING; MECHANISTIC MODELS; PROTECTIVE IMMUNITIES; TIME SERIES MODELS;

VACCINES;

ARTICLE; CROSS PROTECTION; DENGUE; DISEASE TRANSMISSION; HUMAN; IMMUNITY; IMMUNIZATION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEROTYPE; ANIMAL; BIOLOGICAL MODEL; CROSS REACTION; CROSS-PROTECTION; DENGUE VIRUS; FEMALE; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFECTIOUS DISEASE MODELLING; MALE; MOSQUITO; RETROSPECTIVE STUDY; THAILAND; TIME-SERIES MODELS; VIROLOGY;

CROSS-PROTECTION; DENGUE; INFECTIOUS DISEASE MODELLING; TIME-SERIES MODELS;

ANIMALS; CROSS PROTECTION; CROSS REACTIONS; CULICIDAE; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; MALE; MODELS, IMMUNOLOGICAL; RETROSPECTIVE STUDIES; THAILAND;

EID: 84880820798     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2013.0414     Document Type: Article

References (47)

1. Gill PW, Murphy AM. 1977 Naturally acquired immunity to influenza type a: a further prospective study. Med. J. Aust. 2, 761-765.
2. Muelenaer PM, Henderson FW, Hemming VG, Walsh EE, Anderson LJ, Prince GA, Murphy BR. 1991 Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections. J. Infect. Dis. 164, 15-21. (doi:10. 1093/infdis/164.1.15).
3. Sabchareon A et al. 2012 Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. The Lancet 380, 1559- 1567. (doi:10.1016/S0140-6736(12)61428-7).
4. Ferguson NM, Galvani AP, Bush RM. 2003 Ecological and immunological determinants of influenza evolution. Nature 422, 428-433. (doi:10.1038/ nature01509).
5. Cobey S, Lipsitch M. 2012 Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 335, 1376-1380. (doi:10.1126/science.1215947).
6. Babl FE, Pelton SI, Theodore S, Klein JO. 2001 Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades. Clin. Infect. Dis. 32, 1155-1161. (doi:10.1086/319750).
7. Stephens DS. 2007 Conquering the meningococcus. FEMS Microbiol. Rev. 31, 3-14. (doi:10.1111/j. 1574-6976.2006.00051.x).
8. McBride JS, Walliker D, Morgan G. 1982 Antigenic diversity in the human malaria parasite Plasmodium falciparum. Science 217, 254-257. (doi:10.1126/science.6178159).
9. Cooney MK, Fox JP, Kenny GE. 1982 Antigenic groupings of 90 rhinovirus serotypes. Infect. Immun. 37, 642-647.
10. Guzmán MG et al. 2010 Dengue: a continuing global threat. Nat. Rev. Microbiol. 8(Suppl. 12), S7-S16. (doi:10.1038/nrmicro2460).
11. Dunham EJ, Holmes EC. 2007 Inferring the timescale of dengue virus evolution under realistic models of DNA substitution. J. Mol. Evol. 64, 656-661. (doi:10.1007/s00239-006-0278-5).
12. Gibbons RV, Kalanarooj S, Jarman RG, Nisalak A, Vaughn DW, Endy TP, Mammen MP, Srikiatkhachorn A. 2007 Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am. J. Trop. Med. Hyg. 77, 910-913.
13. Martina BEE, Koraka P, Osterhaus ADME. 2009 Dengue virus pathogenesis: an integrated view. Clin. Microbiol. Rev. 22, 564-581. (doi:10.1128/CMR. 00035-09).
14. Dejnirattisai W et al. 2010 Cross-reacting antibodies enhance dengue virus infection in humans. Science's STKE 328, 745-748. (doi:10.1126/science. 1185181).
15. Guzman MG, Alvarez M, Halstead SB. In press. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibodydependent enhancement of infection. Arch. Virol.
16. Guirakhoo F et al. 2006 Research paper live attenuated chimeric yellow fever dengue type 2 (chimerivax-den2) vaccine: phase I clinical trial for safety and immunogenicity. Hum. Vaccines 2, 60-67. (doi:10.4161/hv.2.2.2555).
17. Halstead SB. 2003 Neutralization and antibodydependent enhancement of dengue viruses. In The flaviviruses: pathogenesis and immunity, vol. 60. Advances in Virus Research, pp. 421-467. New York, NY: Academic Press.
18. Ferguson N, Anderson R, Gupta S. 1999 The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiplestrain pathogens. Proc. Natl Acad. Sci. USA 96, 790-794. (doi:10.1073/pnas.96.2.790).
19. Cummings DAT, Schwartz IB, Billings L, Shaw LB, Burke DS. 2005 Dynamic effects of antibodydependent enhancement on the fitness of viruses. Proc. Natl Acad. Sci. USA 102, 15259-15264. (doi:10.1073/pnas.0507320102).
20. Schwartz IB, Shaw LB, Cummings DAT, Billings L, McCrary M, Burke DS. 2005 Chaotic desynchronization of multistrain diseases. Phys. Rev. E 72, 066201. (doi:10.1103/PhysRevE.72.066201).
21. Wearing HJ, Rohani P. 2006 Ecological and immunological determinants of dengue epidemics. Proc. Natl Acad. Sci. USA 103, 11802-11807. (doi:10.1073/pnas.0602960103).
22. Adams B, Holmes EC, Zhang C, Mammen MP, Nimmannitya S, Kalayanarooj S, Boots M. 2006 Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc. Natl Acad. Sci. USA 103, 14234-14239. (doi:10.1073/pnas. 0602768103).
23. Nagao Y, Koelle K. 2008 Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proc. Natl Acad. Sci. USA 105, 2238-2243. (doi:10.1073/pnas.0709029105).
24. Ohainle M et al. 2011 Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci. Transl. Med. 3, 114-128. (doi:10.1126/scitranslmed.3003084).
25. Burke DS et al. 1988 A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38, 172.
26. Sabin AB. 1952 Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1, 30-50.
27. Sabin AB. 1950 The dengue group of viruses and its family relationships. Bacteriol. Rev. 14, 225-232.
28. Kochel TJ, Watts DM, Gozalo AS, Ewing DF, Porter KR, Russell KL. 2005 Cross-serotype neutralization of dengue virus in aotus nancymae monkeys. J. Infect. Dis. 191, 1000-1004. (doi:10.1086/427511).
29. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. 1989 Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40, 444-451.
30. Guzmán MG, Kourí G, Valdés L, Bravo J, Vázquez S, Halstead SB. 2002 Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev. Panam. Salud. Publica 11, 223-227. (doi:10.1590/S1020-49892002000 400003).
31. Nisalak A et al. 2003 Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am. J. Trop. Med. Hyg. 68, 191-202.
32. Child mortality estimates: Thailand. 2013 See http://www.childmortality. org/index.php?r=site/graph&ID=THA-Thailand (accessed on 4 February 2013).
33. Finkenstädt BF, Grenfell BT. 2000 Time series modelling of childhood diseases: a dynamical systems approach. J. R. Stat. Soc. Ser. C Appl. Stat. 49, 187-205. (doi:10.1111/1467-9876.00187).
34. Liu W, Hethcote HW, Levin SA. 1987 Dynamical behavior of epidemiological models with nonlinear incidence rates. J. Math. Biol. 25, 359-380. (doi:10. 1007/BF00277162).
35. Glass K, Xia Y, Grenfell BT. 2003 Interpreting time-series analyses for continuous-time biological models-measles as a case study. J. Theor. Biol. 223, 19-25. (doi:10.1016/S0022- 5193(03)00031-6).
36. Bolker BM. 2011 Ecological models and data in R. Princeton, NJ: Princeton University Press.
37. Akaike H. 1974 A new look at the statistical model identification. IEEE Trans. Automatic Control 19, 716-723. (doi:10.1109/TAC.1974.1100705).
38. Burnham KP, Anderson DR. 2002 Model selection and multimodel inference: a practical information-theoretic approach. Berlin, Germany: Springer.
39. Shrestha S, King AA, Rohani P. 2011 Statistical inference for multi-pathogen systems. PLoS Comput. Biol. 7, e1002135. (doi:10.1371/journal. pcbi. 1002135).
40. R Core Team. 2012 R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
41. Grenfell BT, Pybus OG, Gog JR, Wood JLN, Daly JM, Mumford JA, Holmes EC. 2004 Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303, 327-332. (doi:10.1126/science.1090727).
42. Bharaj P, Chahar HS, Pandey A, Diddi K, Dar L, Guleria R, Kabra SK, Broor S. 2008 Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India. Virol. J. 5, 1. (doi:10.1186/1743- 422X-5-1).
43. Loroño-Pino MA, Cropp CB, Farfan JA, Vorndam AV, Rodriguez-Angulo EM, Rosado-Paredes EP, Flores-Flores LF, Beaty BJ, Gubler DJ. 1999 Common occurrence of concurrent infections by multiple dengue virus serotypes. Am. J. Trop. Med. Hyg. 61, 725-730.
44. Pepin KM, Lambeth K, Hanley KA. 2008 Asymmetric competitive suppression between strains of dengue virus. BMC Microbiol. 8, 28. (doi:10.1186/1471- 2180-8-28).
45. Salje H et al. 2012 Revealing the micro-scale spatial signature of dengue transmission and immunity in an urban population. Proc. Natl Acad. Sci. USA 109, 9535-9538. (doi:10.1073/pnas.1120621109).
46. Hubert B, Halstead SB. 2009 Dengue 1 virus and dengue hemorrhagic fever, French polynesia, 2001. Emerg. Infect. Dis. 15 1265-1270. (doi:10.3201/eid1508. 081500).
47. Guzman MG et al. 2007 Neutralizing antibodies after infection with dengue 1 virus. Emerg. Infect. Dis. 13, 282. (doi:10.3201/eid1302.060539).